Posts Tagged ‘emory liver transplant program’

Emory Liver Transplant Program Ranks Highest in Georgia for Survival

Committed to Delivering the Highest Quality of Care to Patients Near and Far

The Scientific Registry of Transplant Recipients (SRTR) currently ranks the Emory Liver Transplant Program as number one in Georgia for 1-year patient survival. Thanks to our surgeons, providers, nurses and care team (who all work diligently every day), the highest quality of care is possible for our patients in need of a liver transplant. The story of these numbers goes far beyond accolades and recognition. It demonstrates our commitment to constantly innovate, collaborate and care for the patients and families we serve.

SRTR Liver Transplant Rankings

A Leader in the State, a Leader in the Nation

In 1987, transplant surgeons at Emory University Hospital performed the first liver transplant in Georgia. Since that time, we’ve taken the experience and knowledge of our team to build the state’s leading liver transplant program – and one of the best in the nation.

In 2018, our liver transplant team performed 127 adult liver transplants. This positions our program among the top 12 centers in the nation for liver transplant, according to the Organ Procurement and Transplantation Network (OPTN). OPTN links all professionals involved in the U.S. donation and transplantation system. United Network for Organ Sharing (UNOS) serves as the OPTN under contract with the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (DHHS).

Our hands-on experience over the years has given our team unmatched insight, and the know-how to design a treatment plan based on the unique needs of each individual patient. We collaborate across specialties to answer questions and concerns from every angle to help treat liver failure patients.

Focused on Time to Transplant

At Emory, we understand that getting patients on the transplant list quickly is an important step in getting them back to good health. That’s why we’re committed to streamlining the process wherever possible and assigning dedicated resources to help you get the care you need.

This focus is driving results for our patients. Of our 127 patients transplanted in 2018, 31 percent received a liver transplant in one month. A total of 43 percent of patients were transplanted within three months of listing.

An Innovative Approach to Care

Our surgeons, researchers, and care teams are dedicated to offering the latest advances in care for our liver transplant patients. And we are the only hospital in Georgia that provides an intensive care unit dedicated to liver failure and liver transplant.

We’re also on the forefront of cutting-edge research in liver transplantation, allowing us to offer treatments that are only available at a few transplant centers in the country. These treatments include liver transplantation in HIV-positive patients and patients with cholangiocarcinoma (cancer of the bile ducts).

Emory is also one of few transplant centers in the Southeast to offer extracorporeal liver support with the Molecular Adsorbent Recirculating System (MARS ®), which serves as a bridge to transplant for those who experience acute liver failure.

Driving Quality Outcomes

Our dedicated approach to care is driving high-quality outcomes for our patients. With the most recent release of SRTR quality data (June 2019), our team surpassed the expected survival rates of liver transplants and grafts:

  • Actual one-year, risk-adjusted liver transplant survival rate: 94.75%
    • Expected survival rate: 92.52%
  • Actual one-year, risk-adjusted liver graft survival rate: 93.69%
    • Expected survival rate: 90.9%
  • Actual three-year, risk-adjusted liver transplant survival rate: 90.03%
    • Expected survival rate: 86.17%
  • Actual three-year, risk-adjusted liver graft survival rate: 88.92%
    • Expected survival rate: 84.04%

About Emory Liver Transplant Program

Emory Transplant Center has performed more than 2,600 liver transplants. The Liver Transplant Program has a long tradition of treating end-stage liver disease and portal hypertension, providing the full continuum of lifesaving care involved in liver transplant.

Emory’s expert team of liver transplant specialists includes liver transplant surgeons, transplant hepatologists, gastroenterologist, anesthesiologist, pathologist, radiologists and nurses who are all experienced in treating liver failure.


Emory Liver Transplant Program Ranked 2nd Nationally

Emory Transplant Center has great news to share about our Liver Transplant Program. The Scientific Registry of Transplant Recipients (SRTR) just released their January 2017 program specific reports. In this latest release, when comparing adult liver transplant centers across the nation by volume and outcomes (survival at 1 year with a functioning graft), Emory is now ranked SECOND NATIONALLY, bested only by the University of California San Francisco (UCSF).

Below is a portion of a graph that shows the top three ranked adult liver transplant centers by volume with an outcome score of ‘5’, meaning better than expected survival (survival at 1 year with a functioning graft). It is sorted from best to worst.

SRTR National Ranking – Emory Liver Transplant Program Ranked #2*


As you can see, Emory is a large volume liver transplant center which attests to the fact that we do it well and we do it often.

We have also included the outcomes results on a more local level. Emory is ranked HIGHEST in the STATE as evidenced by data in the graph below.

SRTR State Ranking – Emory Liver Transplant Program Ranked #1*


We are incredibly proud of our liver transplant team and would like to thank everyone involved who played a role in achieving this success. We are proud knowing that we give our patients the best care that can be found anywhere in the country.

cta-learn-blueabout the Emory Liver Transplant Program

Emory Liver Transplant Program Appoints New Surgical and Medical Directors

Dr. Ram Subramanian

Dr. Ram Subramanian

Dr. Joseph Magliocca

Dr. Joseph Magliocca

There have been some exciting changes happening at the Emory Transplant Center – specifically within the Emory Liver Transplant Program. Just a little over six months ago, Dr. Joseph (Joe) Magliocca was appointed Surgical Director of the Liver Transplant Program. Dr. Magliocca joined Emory four years ago from Shands Hospital at the University of Florida. His research interests include liver preservation and perfusion with a goal of increasing the number of livers available for transplantation. He serves as an associate editor of the American Journal of Transplantation, the world’s most widely read peer-reviewed publication for transplant professionals. In addition, the American Society of Transplant Surgeons (ASTS) recently appointed him to serve on the PROACTOR Task Force (PROviding better ACcess To ORgans) to investigate ways to increase access to transplantation.

Meanwhile, Dr. James Spivey has stepped down as Medical Director of the Liver Transplant Program to serve as vice chair for clinical affairs in the department of medicine. Dr. Spivey will continue work as a transplant hepatologist, and provide both administrative guidance and clinical expertise at the Emory Transplant Center. In his new role, Dr. Spivey will work closely with chair Dr. David Stephens, Emory Medicine’s senior departmental administrative leadership and the division directors on strategic initiatives and will manage clinical faculty issues.

As a result of Dr. Spivey’s new role, we are proud to announce that Dr. Ram Subramanian has been appointed new Medical Director of the Liver Transplant Program. He has a dual role as both a transplant hepatologist and an intensivist. He began his career at Emory in 2007 and currently is the physician liaison for the abdominal transplant midlevel provider group. His clinical interests include inpatient care before and after liver transplantation, and his research is focused on critical care issues related to hepatic failure and liver transplantation.

While we have come a long way over the past decade, the Emory Liver Transplant Program continues to take steps to improve outcomes for patients, increase the donor pool, develop better surgical and medical techniques that improve quality of life, and create policies and procedures that increase productivity and efficiency in our program. We look forward to guidance under our new leadership.

Emory Liver Transplant Program Raises the Bar

transplant quality measuresAccording to the December 2014 Scientific Registry of Transplant Recipients (SRTR) report, Emory’s adult and pediatric liver transplant program is the second busiest in the nation, establishing the Emory Liver Transplant Program as a leader across the U.S. This feat is made more remarkable by the fact that while volume in the adult program has more than doubled over the past six years, survival outcomes have also dramatically improved, according to the SRTR data.

The Scientific Registry of Transplant Recipients (SRTR) is a national database of transplant statistics. The registry evaluates both the scientific and clinical status of solid organ transplantation for all programs across the nation. This includes the number of transplants performed, wait-list candidates, transplant recipients, and survival statistics for each program.

The liver teams at the Emory Transplant Center and Children’s Healthcare of Atlanta performed 145 adult and 18 pediatric liver transplants (one of which was from a living donor) in calendar year 2014. This is up from a total of 91 adult and pediatric transplants in 2008.

In the most recent SRTR report, Emory’s one-year adult patient and graft survival rates were 92.8% and 89.8%, respectively, both rates were higher than expected. We credit this to the team of talented and committed individuals who work hard work each and every day.

“We have come a long way over the years in the adult program, increasing volume while still improving outcomes,” says Dr. James Spivey, medical director of the program. “Much of the credit goes to a restructuring of our clinical teams to improve outcomes and increase quality of care, productivity of our teams and efficiency in the transplant process for patients. For example, we were able to increase waitlist additions. Through the generous gift of organ donation, this has helped result in increased transplant rates in recent years.”